#097 – BTKi: Was sie können und für wen

from AMSEL für die Ohren – Dein Multiple-Sklerose-Podcast · host AMSEL e.V.

Mit den Bruton-Tyrosinkinase-Hemmern (BTKi) wartet eine ganz neue Wirkstoffklasse in der Pipeline, auch für die progrediente MS. Was man darüber schon weiß, fasst Prof. Mathias Mäurer in diesem Podcast zusammen.______________⁠⁠Multiple Sklerose und Neuerkrankt? ⁠⁠⁠⁠Weitere Informationen zur Multiplen Sklerose mehrmals die Woche⁠⁠⁠⁠Exklusive Informationen rund um MS⁠⁠⁠⁠Multiple Sklerose und Ernährung⁠⁠⁠⁠Multiple Sklerose Forum⁠⁠⁠⁠Spenden für Multiple-Sklerose-Betroffene⁠⁠⁠⁠Unsere weiteren Social-Media-Kanäle⁠⁠⁠⁠AMSEL Mitglied werden⁠

Episode metadata supplied by the publisher feed · Published Apr 3, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

#097 – BTKi: Was sie können und für wen

0:00 15:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AMSEL für die Ohren – Dein Multiple-Sklerose-Podcast?

This episode is 15 minutes long.

When was this AMSEL für die Ohren – Dein Multiple-Sklerose-Podcast episode published?

This episode was published on April 3, 2026.

Can I download this AMSEL für die Ohren – Dein Multiple-Sklerose-Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!